Decontamination and sterilization of medical instruments in museums.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to E Reilly.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Possible mechanisms by which dephenylhydantoin (DPH) controls seizures were examined. The effects of intraperitoneal DPH on seizure discharges within epileptogenic freeze lesions were correlated with DPH action on in vitro potassium uptake within synaptosomes isolated from the same freeze foci. When in vivo DPH suppressed seizure discharges, it stimulated in vitro potassium uptake within synaptosomes incubated in a high-Kplus (10 mM) media. With 2-5 mM Naplus and 10mM Kplus, DPH stimulation of synaptosome potassium uptake was reversed by ouabain. With 50 mM Naplus and 10 mM Kplus, DPH stimulation of potassium uptake was not reversed by ouabain. In low-Kplus (0.2-5 mM) media, DPH did not affect potassium uptake even when sodium concentrations were varied at 10-100 mM. In sham-operated controls and in non-epileptogenic lesions, the effects of DPH on synaptosome potassium uptake were identical to those previously reported in normal brains. These results strongly suggest that DPH controls the epileptogenic state by stimulating potassium uptake within synaptic terminals. DPH controls the epileptogenic state by stimulating potassium uptake within synaptic terminals. DPH enhances synaptic potassium uptake by stimulating the (Naplus-Kplus) pump and a second potassium uptake process which is insensitive to ouabain.
Explore the source record for details and available documents.
Average acoustic-evoked responses (AAER) and EEGs were recorded from the lateral hypothalamus (LH), ventromedial hypothalamus (VMH), medial forebrain bundle (MFB) and reticular formation (RF) of freely behaving rats before and after various doses (0.2, 0.4, 0.8, 1.2 g/5g) of the anesthetic drug, urethane. The effect of a surgical level of urethane (1.2 g/5g) over time (8--14 h) was also studied. Urethane produced a dose-dependent slowing in the EEG frequency. The effect of 1.2 g/kg over time was a bimodal depression of the EEG frequency. Three components of the AAER were recorded consistently and evaluated in terms of amplitude. With increasing doses, the early component (P2) was depressed in the LH2, VMH and MFB, but not in the RF which remained at control values or higher. The later components (N2 and P2) were depressed in all four structures. This suggests that urethane may be blocking the integrative function of the RF, as well as in the thalamus, resulting in lower sensory input to higher CNS structures.